Q3 2023 Holdings
Filed 2023-11-14 | 123 holdings | $513.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomarin Pharmac Inc(BMRN) | COMMON | 09061G101 | $12.8M | 145,090 | 2.5% |
| Lilly ELI & Co(LLY) | COMMON | 532457108 | $12.5M | 23,265 | 2.4% |
| Option Care Health(OPCH) | COMMON | 68404L201 | $12.1M | 375,500 | 2.4% |
| Conmed Corp(CNMD) | COMMON | 207410101 | $11.5M | 114,000 | 2.2% |
| Privia Health Group(PRVA) | COMMON | 74276R102 | $11.4M | 494,622 | 2.2% |
| R1 RCM Inc(RCM1USD) | COMMON | 77634L105 | $11.2M | 744,194 | 2.2% |
| Healthequity Inc(HQY) | COMMON | 42226A107 | $10.5M | 143,875 | 2.0% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $10.4M | 383,142 | 2.0% |
| Radnet Inc(RDNT) | COMMON | 750491102 | $10.4M | 369,134 | 2.0% |
| Atricure Inc(ATRC) | COMMON | 04963C209 | $10.4M | 236,532 | 2.0% |
| Amicus Therapeutics(FOLD) | COMMON | 03152W109 | $9.8M | 803,464 | 1.9% |
| Axonics Inc(AXNX*) | COMMON | 05465P101 | $9.7M | 172,950 | 1.9% |
| Inari MED Inc(NARIUSD) | COMMON | 45332Y109 | $9.0M | 138,043 | 1.8% |
| Johnson & Johnson(JNJ) | COMMON | 478160104 | $8.9M | 56,850 | 1.7% |
| Insmed Inc(INSM) | COMMON | 457669307 | $8.8M | 347,392 | 1.7% |
| Unitedhealth GRP Inc(UNH) | COMMON | 91324P102 | $8.5M | 16,925 | 1.7% |
| Blueprint Medicines(2L9) | COMMON | 09627Y109 | $8.3M | 165,890 | 1.6% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $8.3M | 172,407 | 1.6% |
| Icon PLC(ICLR) | SHS | G4705A100 | $8.3M | 33,663 | 1.6% |
| Mineralys Therapeuti(MLYS) | COMMON | 603170101 | $8.0M | 840,759 | 1.6% |
| Mirati Therapeutics(MRTXEUR) | COMMON | 60468T105 | $7.9M | 181,904 | 1.5% |
| Zentalis Pharmaceu(ZNTL) | COMMON | 98943L107 | $7.8M | 386,525 | 1.5% |
| Amgen Inc(AMGN) | COMMON | 031162100 | $7.5M | 28,065 | 1.5% |
| Immunogen Inc(IMGNEUR) | COMMON | 45253H101 | $7.4M | 464,112 | 1.4% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $6.8M | 244,260 | 1.3% |
| Arcus Biosciences(RCUS) | COMMON | 03969F109 | $6.7M | 375,456 | 1.3% |
| Intra Cellular Thera(ITCIEUR) | COMMON | 46116X101 | $6.4M | 123,680 | 1.3% |
| Vaxcyte Inc(PCVX) | COMMON | 92243G108 | $6.2M | 121,230 | 1.2% |
| Tenet Healthcare(THC) | COMMON | 88033G407 | $6.0M | 91,500 | 1.2% |
| Abbvie Inc(ABBV) | COMMON | 00287Y109 | $5.9M | 39,300 | 1.1% |
| Insulet Corp(PODD) | COMMON | 45784P101 | $5.9M | 36,725 | 1.1% |
| Goodrx Hldgs Inc(GDRX) | COMMON | 38246G108 | $5.7M | 1,007,000 | 1.1% |
| Merck & Co Inc(MRK) | COMMON | 58933Y105 | $5.7M | 55,000 | 1.1% |
| Moonlake Immunothera(MLTX) | CLASS A | 61559X104 | $5.6M | 97,965 | 1.1% |
| Halozyme Therapeutic(HALO) | COMMON | 40637H109 | $5.6M | 146,000 | 1.1% |
| Merit Medical SYS(MMSI) | COMMON | 589889104 | $5.5M | 79,000 | 1.1% |
| Olema Pharmaceutical(OLMA) | COMMON | 68062P106 | $5.4M | 437,652 | 1.1% |
| Denali Therapeutics(DNLI) | COMMON | 24823R105 | $5.3M | 254,941 | 1.0% |
| Boston Scientific(BSX) | COMMON | 101137107 | $5.2M | 98,976 | 1.0% |
| Pfizer Inc(PFE) | COMMON | 717081103 | $5.2M | 157,400 | 1.0% |
| Glaukos Corp(GKOS) | COMMON | 377322102 | $5.2M | 69,000 | 1.0% |
| Alnylam Pharmacuetcl(ALNY) | COMMON | 02043Q107 | $5.1M | 28,960 | 1.0% |
| Abbott Labs(ABT) | COMMON | 002824100 | $5.1M | 52,498 | 1.0% |
| Lantheus Hldgs Inc(LNTH) | COMMON | 516544103 | $4.9M | 70,987 | 1.0% |
| Vera Therapeutics(VERA) | CL A | 92337R101 | $4.9M | 357,139 | 1.0% |
| Bridgebio Pharma Inc(BBIO) | COMMON | 10806X102 | $4.8M | 180,195 | 0.9% |
| Rocket Pharmaceutica(RCKT) | COMMON | 77313F106 | $4.7M | 227,030 | 0.9% |
| Replimune Group Inc(REPL) | COMMON | 76029N106 | $4.6M | 271,056 | 0.9% |
| Iovance Biotherapeut(IOVA) | COMMON | 462260100 | $4.5M | 985,000 | 0.9% |
| Karuna Therapeutics | COMMON | 48576A100 | $4.4M | 25,980 | 0.9% |